In AYAs, the ASH guideline panel recommends pediatric-inspired (asparaginase-containing) regimens for treatment-naïve B-ALL and T-ALL, and blinatumomab for relapsed/refractory B-ALL.

Genomically matched therapies associated with investigational evidence only did not improve survival versus unmatched therapies. Only a minority of patients received genomically matched therapies, and ...

ZIBO CITY, SHANDONG PROVINCE, CHINA, March 5, 2026 /EINPresswire.com/ -- The global ceramic fiber market has grown ...

Pillar Biosciences today announced the launch of the oncoReveal® Rapid AML Panel, a focused research-use-only (RUO) DNA next-generation sequencing (NGS) panel designed to help laboratories generate ...

Leerink Partners 2026 Global Healthcare Conference March 8 – 11, 2026, Miami, Florida Fireside Chat: March 11, 8:40 a.m. ET Trevi Representatives: Jennifer Good, President and CEO, and James Cassella, ...

The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032, registering a CAGR of 7.47% during 2024--2032. Growth is underpinned by ...

Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026Improved balance sheet through multiple direct offerings; ...

Stepping off the night train, full of memories of his life there three decades ago, the writer finds a changed city fighting for survival ...

Q2 2026 Earnings Call February 26, 2026 5:00 PM ESTCompany ParticipantsPaul Hughes - Joint Company SecretarySilviu Itescu ...

Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026Improved balance sheet through multiple direct offerings; complet ...

The FDA has approved teclistamab (Tecvayli) daratumumab and hyaluronidase-fihj (Darzalex Faspro) for the treatment of patients with relapsed or refractory multiple myeloma following at least 1 line of ...

A woman in her 40s presented with progressive cognitive decline, expressive language difficulty and episodic confusion. Her initial symptoms were misattributed to psychiatric illness, and later to ...